Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 610-623-5 | CAS number: 511540-64-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitization (OECD 429, RL1): mouse (m/f), not skin sensitizing
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July 18 - September 08, 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands B.V. Postbus 6174 NL - 5960 AD Horst
- Age at study initiation: Pre-test: 7-8 weeks
- Weight at study initiation: 20.1-20.5 g
- Housing: single
- Diet (e.g. ad libitum): pelleted standard diet (Harlan Winkelmann GmbH, Borchen, Germany), ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: yes
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 + 3 °C
- Humidity (%): 30 - 82 %
- Photoperiod (hrs dark / hrs light): 12/12
HUSBANDRY
Cage type: Makrolon, Type I with wire mesh top )EHRET GmbH, Emmendingen, Germany)
Bedding: granulated soft wood bedding (Harlan Winkelmann GmbH, Borchen, Germany) - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 12.5, 25, and 50 % (w/w)
- No. of animals per dose:
- 4
- Details on study design:
- PREPARATION OF TEST MATERIAL:
The test item was placed into a volumetric flask glass beaker on a tared balance and the vehicle was quantitatively added. The test concentrations were prepared serially. Homogeneity of the test material was maintained during treatment with the magnetic stirrer. Preparations were made freshly before each dosing occation.
RANGE FINDING TESTS:
To determine the highest non-irritant test concentration or the highest technically applicable concentration, a pretest (non GLP) was performed in 2 mice. The data showed that the highest concentration which could be technically used was a 50 % solution. The treatment of the mice with 6.25, 12.5, 25 and 50 % test item in Acetone/Olive oil (4+1) did not show any signs of severe local irritation or systemic toxicity.
MAIN STUDY
Each test group of mice was treated by topical application to the dorsal surface of each ear lobe (left and right) with different test item concentrations. The application volume of 25 µl was spread over the entire dorsal surface of each ear lobe onca daily for 3 consecutive days. A further group of mice was treated with an equivalent volume of the relevant vehicle alone (controls).
5 days after the first topical application, all mice were administered with 250 µl of 78.6µCi/mL 3HTdR (corresponding to 19.65 µL 3HdTR per animal) by intravenous injection via tail vein.
Approx. 5 days after treatment with 3HTdR all mice were euthanized . The draining lymph nodes were excised and pooled per group. Single cell suspensions were prepared and incubated at ca. 4 °C for at least 18 h for precipitation of macromolecules. The precipitates were then resuspended in 5 % Trichloroacetic acid and transferred to glass scintillation vials with scintillation liquid (Ultima gold) and thoroughly mixed.
The level of 3HTdR incorporation was then measured on a ß-scintillation counter
In the first main experiment 3/4 animals treated with the high dose died and the one remaining did not show any signs of sensitisation. In order to confirm this data the high dose test group was repeated. In the repeated experiment the treated animals were observed daily for clinical signs of toxicity.
INTERPRETATION OF RAW DATA:
A test item is considered a sensitizer in the LLNA if the following criteria are fulfilled:
- Exposure to at least one concentration of the test material resulted in an incorporation of 3HTdR at least 3x greater than that recorded in controls, as indicated by SI.
The data are compatible with a conventional dose-response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
OBSERVATIONS:
In addition to the sensitising reactions the following observations and data were recorded during the test and observation period:
Mortality/Viability: once daily from experimental start to necropsy.
Body weights: prior to first application and prior to treatment with 3HTdR
Clinical signs: at 1-2 h after each application, especially the treatment sites were observed carefully. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Mean values and standard deviations were calculated
- Positive control results:
- Conc. SI
0%: 1.00
5% 2.04
10% 2.88
25% 3.56 - Key result
- Parameter:
- SI
- Value:
- 0.72
- Test group / Remarks:
- Test Group 12.5 %
- Key result
- Parameter:
- SI
- Value:
- 1.15
- Test group / Remarks:
- Test Group 25 %
- Key result
- Parameter:
- SI
- Value:
- 0.09
- Test group / Remarks:
- Test Group 50 % (first main experiment)
- Remarks on result:
- other:
- Remarks:
- (1 remaining animal)
- Key result
- Parameter:
- SI
- Value:
- 0.99
- Test group / Remarks:
- Test Group: 50 % (repetition of main experiment)
- Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- Control Group
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
The EC3 value could not be calculated since none of the tested concentrations induced an SI >3.
VIABILITY/MORTALITY
First main experiment:
3 animals died after the 3rd application at the high dose (50 %)
Repetition of the main experiment:
1 animal was euthanized an the day after the 3rd application.
CLINICAL OBSERVATIONS
First main experiment:
The animals did not show any clinical signs at the low and mid dose during the course of the study. The the high dose, all 4 animals showed redness at the ears after the 2nd application.
Repetition of the main experiment:
The animals treated with the high dose showed the following signs after the last application: reduction of the spontaneous activity, eyelid closure and ruffled fur. On the day after the last application one animal was moribund and was therefore euthanised.
BODY WEIGHTS
The body weight range was within the range commonly recrded for animals of this strain and age. - Interpretation of results:
- not sensitising
- Conclusions:
- The test material was not a skin sensitiser under the test conditions of this study.
- Executive summary:
Objective
The purpose of this Local Lymph Node Assay was to assess the skin sensitizing potential of the test material when administered to the dorsum of both ears of mice.
This study should provide a rational basis for risk assessment to the sensitizing potential of the test item in man.
Study Design
For this purpose a local lymph node assay was performed using test item concentrations of 12.5, 25, and 50%. The highest concentration tested was the highest concentration that could technically be achieved.
Results
First main experiment:
The animals did not show any clinical signs at the low and mid dose during the course of the study. The the high dose, all 4 animals showed redness at the ears after the 2nd application.
Repetition of the main experiment:
The animals treated with the high dose showed the following signs after the last application: reduction of the spontaneous activity, eyelid closure and ruffled fur. On the day after the last application one animal was moribund and was therefore euthanised.
In this study Stimulation Indices (S.I.) of 0.72, 1.15, and 0.99 were determined with the test item at concentrations of 10, 25, and 50% in Acetone/Olice oil (4 +1), respectively.
Conclusion
The test material was not a skin sensitiser under the test conditions of this study.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
LLNA
The purpose of this Local Lymph Node Assay was to assess the skin sensitizing potential of the test material when administered to the dorsum of both ears of mice. For this purpose a local lymph node assay was performed using test item concentrations of 12.5, 25, and 50%. The highest concentration tested was the highest concentration that could technically be achieved.
First main experiment:
The animals did not show any clinical signs at the low and mid dose during the course of the study. The the high dose, all 4 animals showed redness at the ears after the 2nd application.
Repetition of the main experiment:
The animals treated with the high dose showed the following signs after the last application: reduction of the spontaneous activity, eyelid closure and ruffled fur. On the day after the last application one animal was moribund and was therefore euthanised.
In this study Stimulation Indices (S.I.) of 0.72, 1.15, and 0.99 were determined with the test item at concentrations of 10, 25, and 50% in Acetone/Olice oil (4 +1), respectively.
The test material was not a skin sensitiser under the test conditions of this study.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available data on skin sensitization do not meet the criteria for classification according to Regulation (EC) 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.